Relacorilant plus nab-paclitaxel for the treatment of metastatic pancreatic ductal adenocarcinoma: results from the open-label RELIANT study.
Borazanci EH, Bahary N, Chung V, Huyck TK, Kio EA, Chiorean EG, Skeel RT, Alese OB, Cardin DB, Fountzilas C, Hanna WT, Leal AD, Lee V, Noonan AM, Philip PA, Wainberg ZA, Pashova H, Mann G, Oberstein PE.
Borazanci EH, et al. Among authors: cardin db.
Oncologist. 2024 Nov 4;29(11):957-965. doi: 10.1093/oncolo/oyae210.
Oncologist. 2024.
PMID: 39191530
Free PMC article.
Clinical Trial.